Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global MM Market Portraiture
2.2. Global MM Market, by Application, 2017 (US$ Mn)
2.3. Global MM Market, by Point of Sale, 2017 (US$ Mn)
2.4. Global MM Market, by Geography, 2017 (US$ Mn)
Chapter 3. Medical Marijuana (MM) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global MM Market, by Key Players, 2017
Chapter 4. Global Medical Marijuana (MM) Market, by Application
4.1. Overview
4.2. Chronic Pain
4.3. Neurological Disorders
4.4. Cancer
4.5. Others (Anorexia, Nausea etc.)
Chapter 5. Global Medical Marijuana (MM) Market, by Point of Sale
5.1. Overview
5.2. Hospital Pharmacy
5.3. Dispensaries
Chapter 6. Global Medical Marijuana (MM) Market, by Geography
6.1. Overview
6.2. North America MM Market Analysis, 2016 – 2026
6.2.1. North America MM Market, by Application, 2016 – 2026 (US$ Mn)
6.2.2. North America MM Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
6.2.3. North America MM Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe MM Market Analysis, 2016 – 2026
6.3.1. Europe MM Market, by Application, 2016 – 2026 (US$ Mn)
6.3.2. Europe MM Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
6.3.3. Europe MM Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Latin America MM Market Analysis, 2016 – 2026
6.4.1. Latin America MM Market, by Application, 2016 – 2026 (US$ Mn)
6.4.2. Latin America MM Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
6.4.3. Latin America MM Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. Brazil
6.4.3.2. Mexico
6.4.3.3. Rest of Latin America
6.5. Rest of World MM Market Analysis, 2016 – 2026
6.5.1. RoW MM Market, by Application, 2016 – 2026 (US$ Mn)
6.5.2. RoW MM Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
6.5.3. RoW MM Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Australia
6.5.3.2. Israel
6.5.3.3. Rest of World
Chapter 7. Company Profiles
7.1. AbbVie, Inc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. CannaGrow Holdings, Inc.
7.3. Canopy Growth Corporation, Inc.
7.4. GW Pharmaceuticals, Plc.
7.5. Insys Therapeutics, Inc.
7.6. Novartis AG
7.7. Lexaria Corporation
7.8. Pfizer, Inc.
7.9. Teva Pharmaceutical Industries Ltd.
7.10. United Cannabis Corporation
List of Figures
FIG. 1 Medical Marijuana (MM) Market: Research Methodology
FIG. 2 MM Market Segmentation
FIG. 3 Global MM Market, by Application, 2017 (US$ Mn)
FIG. 4 Global MM Market, by Point Of Sale, 2017 (US$ Mn)
FIG. 5 Global MM Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2017
FIG. 7 Competitive Analysis: Global MM Market, by Key Players, 2017
FIG. 8 Global Chronic Pain Market for Medical Marijuana, 2016 – 2026 (US$ Mn)
FIG. 9 Global Neurological Disorders Market for Medical Marijuana, 2016 – 2026 (US$ Mn)
FIG. 10 Global Cancer Market for Medical Marijuana, 2016 – 2026 (US$ Mn)
FIG. 11 Global Others Market for Medical Marijuana, 2016 – 2026 (US$ Mn)
FIG. 12 Global Hospital Pharmacy Market for Medical Marijuana, 2016 – 2026 (US$ Mn)
FIG. 13 Global Dispensaries Market for Medical Marijuana, 2016 – 2026 (US$ Mn)
FIG. 14 U.S. MM Market, 2016 – 2026 (US$ Mn)
FIG. 15 Canada MM Market, 2016 – 2026 (US$ Mn)
FIG. 16 U.K. MM Market, 2016 – 2026 (US$ Mn)
FIG. 17 Germany MM Market, 2016 – 2026 (US$ Mn)
FIG. 18 Rest of Europe MM Market, 2016 – 2026 (US$ Mn)
FIG. 19 Brazil MM Market, 2016 – 2026 (US$ Mn)
FIG. 20 Mexico MM Market, 2016 – 2026 (US$ Mn)
FIG. 21 Rest of Latin America MM Market, 2016 – 2026 (US$ Mn)
FIG. 22 Australia MM Market, 2016 – 2026 (US$ Mn)
FIG. 23 Israel MM Market, 2016 – 2026 (US$ Mn)
FIG. 24 Rest of the World MM Market, 2016 – 2026 (US$ Mn)
List of Tables
TABLE 1 Global Medical Marijuana (MM) Market Portraiture
TABLE 2 Global MM Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 3 Global MM Market , by Point Of Sale, 2016 – 2026 (US$ Mn)
TABLE 4 Global MM Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America MM Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 6 North America MM Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
TABLE 7 North America MM Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe MM Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 9 Europe MM Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
TABLE 10 Europe MM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Latin America MM Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 12 Latin America MM Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
TABLE 13 Latin America MM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Rest of the World MM Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 15 Rest of the World MM Market, by Point Of Sale, 2016 – 2026 (US$ Mn)
TABLE 16 Rest of the World MM Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 AbbVie, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 CannaGrow Holdings, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 Canopy Growth Corporation, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 GW Pharmaceuticals, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Insys Therapeutics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Lexaria Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Teva Pharmaceuticals Industries, Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 United Cannabis Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)